Nitric oxide. A key mediator in sepsis and endotoxaemia?

Journal of Physiology and Pharmacology

Volumn 48, Issue 4, 1997, Pages 493-506

  Parratt, J R ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Inducible nitric oxide synthase; Myocardial depression; Selective inhibitors; Vascular hyporeactivity

Indexed keywords

1 AMINO 2 HYDROXY DERIVATIVE; ACETYLCHOLINE; AMINOETHYLTHIOUREA; BRADYKININ; CYCLIC GMP; ENDOTOXIN; METHYLISOTHIOUREA; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; ENDOTOXEMIA; HEART OUTPUT; HYPOTENSION; KNOCKOUT MOUSE; MORTALITY; NONHUMAN; SEPSIS; SEPTIC SHOCK; VASCULAR RESISTANCE;

ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; ENDOTOXEMIA; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEPSIS;

EID: 0031452295     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Neugebauer EA, Holaday JW (eds.) Handbook of Mediators in Septic Shock, CRC Press, Boca Raton, 1995.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
3. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharm 1991; 41: 485-490.
4. Evans T, Carpenter A, Kinderman H, Cohen J. Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41: 77-81.
5. Groenveld ABJ, Bronsveld W, Thijs LJ. Hemodynamic determinants of mortality in human septic shock. Surgery 1996; 99: 140-152.
6. Parrillo JE. Cardiovascular dysfunction in humans with septic shock. In Update in Intensive Care and Emergency Medicine. JL Vincent (ed). Springer Berlin 1986; 1: P265-274.
7. Moncada S, Palmer RNJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
8. Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Schott C, Stoclet JC. Impaired vascular reactivity in the rat following endotoxin treatment can be endothelium independent, yet involves the L-arginine pathway. J Physiol 1990; 423: 18P.
9. Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet JC. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 1990; 171: 562-568.
10. Fleming I, Gray GA, Schott CA, Stoclet JC. Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. Eur J Pharmacol 1991; 200: 375-376.
11. Schneider F, Bucher B, Schott C, Andre A, Julou-Schaeffer G, Stoclet JC. Effect of bacterial lipopolysaccharide on function of rat small femoral arteries. Am J Physiol 1994; 266: H191-H198.
12. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC. Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 1990; 259: H1038-H1043.
13. Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stocler JC. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol 1991; 103: 1047-1052.
14. Gray GA, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet JC. An investigation of the effect of inhibitors of the L-arginine pathway on endotoxin-induced vascular hyporeactivity in vitro. Br J Pharmacol 1991; 103: 1218-1224.
15. Kumar A, Parrillo JE. Myocardial depression in septic shock: role of nitric oxide and other mediators. In Shock, Sepsis and Organ Failure - Nitric Oxide. G Schlag, H Redl (eds). Springer, Berlin, 1995; pp. 322-341.
16. Kaszaki J, Wolfard A, Bari F, Boros M, Parratt JR, Nagy S. Effect of nitric oxide synthase inhibition on myocardial contractility in anaesthetised normal and endotoxemic dogs. Shock 1996; 6: 279-285.
17. Guc MO, Furman BL, Parratt JR. Endotoxin induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 1990; 101: 913-919.
18. Guc MO, Gray GA, Furman BL, Parratt JR. Endotoxin-induced impairment of vasodepressor responses in the pithed rat. Eur J Pharmacol 1991; 204: 63-70.
19. Fatehi-Hassanabad Z, Parratt JR, Furman BL. Endotoxin-induced inhibition of mesenteric vasodilator responses to acetylcholine, bradykinin, and post-occlusion hyperemia in anaesthetised rats. Shock 1996; 6: 371-376.
20. Altura BM, Gebrewold A, Burton RW. Failure of microscopic metarterials to elicit vasodilator responses to acetylcholine, bradykinin, histamine and substance P after ischemic shock, endotoxemia and trauma: possible role of endothelial cells. Microcirc Endothel Lymph 1985; 2: 121-134.
21. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6: 79-88.
22. Fatehi-Hassanabad Z, Burns H, Aughey EA et al. Effects of L-canavanine, an inhibitor of inducible nitric oxide synthase, on endotoxin mediated shock in rats. Shock 1996; 6: 194-200.
23. Parratt JR. Nitric oxide and cardiovascular dysfunction in sepsis and endotoxaemia: an introduction and an overview. In Shock, Sepsis, and Organ Failure - Nitric Oxide. G Schlag, H Redl (eds). Springer, Berlin, 1995; pp. 1-21.
24. Radomski MW. The role of nitric oxide in vascular haemostasis and thrombosis, implications for septicaemia and cell damage. In Shock, Sepsis, and Organ Failure - Nitric Oxide. G Schlag, H Redl (eds). Springer, Berlin, 1995; pp. 180-196.
25. Thiemermann C. Inhibition of induction or activity of nitric oxide synthase: novel approaches for the therapy of circulatory shock. In Shock, Sepsis, and Organ Failure - Nitric Oxide. G Schlag, H Redl (eds). Springer, Berlin, 1995; pp. 30-53.
26. Vincent JL, Preiser JC, Zhang H. Blocking the effect of nitric oxide in septic shock. In: Role of nitric oxide in sepsis and ARDS. MP Fink, D Payen (eds). Springer, Berlin, 1995; pp. 253-273.
27. Ruetten H, Southan GJ, Abate A, Thiemermann C. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 1996; 118: 261-270.
28. Southan GJ, Szabo C, Thiemermann C. Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995; 114: 510-516.
29. Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996; 51: 383-394.
30. Boughton-Smith NK, Evans SM, Laszlo F, Whittle BJR, Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993; 110: 1189-1195.
31. Wu S, Furman BL, Parratt JR. Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxin. Br J Pharmacol 1996; 118: 2157-2163.
32. Wu S, Furman BL, Parratt JR. Attenuation by dexamethasone of endotoxin protection against ischaemia-induced ventricular arrhythmias. Br J Pharmacol 1994; 113: 1083-1084.
33. ATP channels mediate late preconditioning against infraction produced by monophosphoryl lipid A. Am J Physiol 1996; 271: H2723-H2729.
34. Vegh A, Papp JG, Elliott GT, Parratt JR. Pretreatment with monophosphoryl lipid A (MPL-C) reduces ischaemia-reperfusion arrhythmias in dogs. J Mol Cell Cardiol 1996; 28: A217.
35. Yao Z, Elliott GT, Gross GJ. Monophosphoryl lipid A preserves myocardial contractile function following multiple, brief periods of coronary occlusion in dogs. Pharmacology 1995; 51: 152-159.
36. Astiz ME, Rackow EC, Still JG et al. Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double blind, randomised, controlled trial. Critical Care Med 1995; 23: 9-17.
37. Eschen KB von. Monophosphoryl lipid A and immunotherapy. In: Bacterial Endotoxic Lipopolysaccharides. Immunopharmacology and Pathophysiology. JL Ryan, DC Morrison (eds). CRC Press, Boca Raton, 1996; 2: pp. 411-428.
38. Wei XQ, Charles IG, Smith A et al. Altered immune responses in mice lacking inducible oxide synthase. Nature 1995; 375: 408-411.
39. MacMicking JD, Nathan C, Hom G et al. Altered response to bacterial infection and endotoxin shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81: 641-650.